EE Q1 2026 Earnings EPS Misses Estimates Amid Challenging Conditions Xenetic Biosciences Q2 2025 Earnings Narrowed Loss Exceeds Expectations Amid Oncology Pipeline Progress NNDM Q1 2026 Earnings Loss Per Share of 034 as Stock Rises Amid Strategic Progress RIME Q1 2026 Earnings NarrowerThanExpected Loss Drives Stock Higher BEAM Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Market Response CDLX Q1 2026 Earnings NarrowerThanExpected Loss Signals Operating Discipline